HCA Holdings (HCA) Tops Q2 EPS by 19c ; Offers Guidance

HCA Holdings (NYSE: HCA) reported Q2 EPS of $7.59, $0.19 better than the analyst estimate of $7.40. Revenue for the quarter came in at $20.23 billion versus the consensus estimate of $19.38 billion.

GUIDANCE:

HCA Holdings sees FY2026 EPS of $28.70-$30.50, versus the consensus of $29.92. HCA Holdings sees FY2026 revenue of $77-79.5 billion, versus the consensus of $78.49 billion.

For earnings history and earnings-related data on HCA Holdings (HCA) click here.

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Arcos Dorados (ARCO) Tops Q2 EPS by 7c
• Stratasys (SSYS) Tops Q2 EPS by 2c ;; Offers Guidance